Acorah Software Products - Accounts Production 19.2.450 false true 30 April 2024 1 May 2023 false 2 June 2026 true 1 May 2024 30 April 2025 30 April 2025 10826548 Mr D J Bunker Mr J B Callister Mr D M Sedgwick iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10826548 2024-04-30 10826548 2025-04-30 10826548 2024-05-01 2025-04-30 10826548 frs-core:CurrentFinancialInstruments 2025-04-30 10826548 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2025-04-30 10826548 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-05-01 2025-04-30 10826548 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-04-30 10826548 frs-core:ShareCapital 2024-04-30 10826548 frs-core:ShareCapital 2025-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses 2024-05-01 2025-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2024-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses 2025-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses 2024-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses 2025-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses frs-core:PriorPeriodErrorIncreaseDecrease 2024-04-30 10826548 frs-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 10826548 frs-bus:FullAccounts 2024-05-01 2025-04-30 10826548 frs-bus:MediumEntities 2024-05-01 2025-04-30 10826548 frs-bus:Audited 2024-05-01 2025-04-30 10826548 frs-bus:Medium-sizedCompaniesRegimeForAccounts 2024-05-01 2025-04-30 10826548 frs-bus:Medium-sizedCompaniesRegimeForDirectorsReport 2024-05-01 2025-04-30 10826548 frs-bus:OrdinaryShareClass1 2024-05-01 2025-04-30 10826548 frs-bus:OrdinaryShareClass1 2025-04-30 10826548 frs-core:DeferredTaxation 2024-05-01 2025-04-30 10826548 frs-core:DeferredTaxation 2024-04-30 10826548 frs-core:DeferredTaxation 2025-04-30 10826548 frs-core:CostValuation 2024-04-30 10826548 frs-core:CostValuation 2025-04-30 10826548 frs-core:ProvisionsForImpairmentInvestments 2024-04-30 10826548 frs-core:ProvisionsForImpairmentInvestments 2025-04-30 10826548 frs-bus:Director1 2024-05-01 2025-04-30 10826548 frs-bus:Director1 2025-04-30 10826548 frs-bus:Director2 2024-05-01 2025-04-30 10826548 frs-bus:Director2 2025-04-30 10826548 frs-bus:Director3 2024-05-01 2025-04-30 10826548 frs-bus:Director3 2025-04-30 10826548 frs-bus:Director4 2024-05-01 2025-04-30 10826548 frs-bus:Director4 2025-04-30 10826548 1 2024-05-01 2025-04-30 10826548 frs-countries:EnglandWales 2024-05-01 2025-04-30 10826548 2023-04-30 10826548 2024-04-30 10826548 2023-05-01 2024-04-30 10826548 frs-core:CurrentFinancialInstruments 2024-04-30 10826548 frs-core:ShareCapital 2023-04-30 10826548 frs-core:ShareCapital 2024-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses 2023-05-01 2024-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2023-04-30 10826548 frs-core:RetainedEarningsAccumulatedLosses 2024-04-30 10826548 frs-bus:OrdinaryShareClass1 2023-05-01 2024-04-30 10826548 1 2023-05-01 2024-04-30
Registered number: 10826548
Absolute Healthcare North Limited
Strategic Report, Directors' Report and
Financial Statements
For The Year Ended 30 April 2025
Absolute Healthcare North Limited
Contents
Contents

| Page
--- | ---
Strategic Report | 1
Directors' Report | 2—3
Independent Auditor's Report | 4—7
Profit and Loss Account | 8
Statement of Comprehensive Income | 9
Balance Sheet | 10
Statement of Changes in Equity | 11
Statement of Cash Flows | 12
Notes to the Statement of Cash Flows | 13
Notes to the Financial Statements | 14—17

Page 1
Absolute Healthcare North Limited
Strategic Report
For The Year Ended 30 April 2025
Strategic Report
The directors present their strategic report for the year ended 30 April 2025.
Principal Risks and Uncertainties
On behalf of the board

Mr D J Bunker Director
29 May 2026

Page 1
Page 2
Absolute Healthcare North Limited
Company No. 10826548
Directors' Report For The Year Ended 30 April 2025
Directors' Report
The directors present their report and the financial statements for the year ended 30 April 2025.
Principal Activity
The company's principal activity continues to be that of the provision of healthcare for the elderly.
Directors
The directors who held office during the year were as follows:

Dr M S Pawar | Resigned | 20/01/2026
Mr D J Bunker | Appointed | 20/01/2026
Mr J B Callister | Appointed | 20/01/2026
Mr D M Sedgwick | Appointed | 20/01/2026

Statement of Directors' Responsibilities
The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards, comprising FRS102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing the financial statements the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgments and accounting estimates that are reasonable and prudent;
- state whether applicable United Kingdom Accounting Standards, comprising FRS102, have been followed subject to any material departures disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Statement of Disclosure of Information to Auditors
In the case of each director in office at the date the Directors' Report is approved:

- so far as the director is aware, there is no relevant audit information of which the company's auditors are unaware; and
- they have taken all the steps that they ought to have taken as directors in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information.

Page 2
Page 3
Absolute Healthcare North Limited
Directors' Report (continued)
For The Year Ended 30 April 2025
Independent Auditors
The auditors, Nuvo Audit Limited, have indicated their willingness to continue in office and a resolution concerning their re-appointment will be proposed at the Annual General Meeting.
On behalf of the board

Mr D J Bunker Director
29 May 2026

Page 3
Page 4
Independent Auditor's Report
to the Members of
Absolute Healthcare North Limited
Independent Auditor's Report
Opinion
We have audited the financial statements of Absolute Healthcare North Limited for the year ended 30 April 2025 which comprise the Profit and Loss Account, Statement of Comprehensive Income, Balance Sheet, Statement of Changes of Equity, Cash Flow Statement and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".
In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 30 April 2025 and of its profit/(loss) for the year then ended;
- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for Opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
During our audit, we were unable to obtain sufficient appropriate audit evidence regarding the closing balance sheet as at 30 April 2023 as the comparative financial statements were not audited. As a result, we cannot express an opinion on the accuracy of the opening balance sheet for this financial period although we are not aware of any material misstatements that would impact the financial statements for the year ending 30 April 2024.
Conclusions Relating to Going Concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the entity's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other Information
The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on Other Matters Prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:

- the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Page 4
Page 5
Independent Auditor's Report (continued)
to the Members of
Absolute Healthcare North Limited
Matters on Which We Are Required to Report by Exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records or returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of Directors
As explained more fully in the Directors' Responsibilities Statement set out on page 2—3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Page 5
Page 6
Independent Auditor's Report (continued)
to the Members of
Absolute Healthcare North Limited
Auditor's Responsibilities for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
Detecting irregularities, including fraud
Based on our knowledge and understanding of the Company and industry, we identified that the key risk of fraud or non-compliance with laws and regulations related to:

- Management bias in respect of accounting estimates and judgements made.
- Management override of control.
- Posting of unusual journals or transactions.
- Non-compliance with CQC regulations.

We focused on those areas that could give rise to a material misstatement in the Company financial statements. Our procedures included but were not limited to:

- Enquiring of management and those charged with governance around actual and potential litigation and claims, including instances of non-compliance with laws and regulations and fraud.
- Reviewing legal expenditure in the year to identify instances of non-compliance with laws and regulations and fraud.
- Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations.
- Performing audit work over the risk of management override of controls including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business.
- Performing analytical procedures to identify any unusual or unexpected relationships that may indicate an increased risk of material misstatement as a result of fraud, or management override.
- Assessing accounting estimates which have a material impact of the year end accounts, to determine if there is indication of management bias.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.
It is the primary responsibility of management, with the oversight of those charged with governance, to ensure that the Group’s operations are conducted in accordance with the provisions of laws and regulations and for the prevention and detection of fraud.
Our audit did not identify any key audit matters relating to the detection of irregularities including fraud. However, despite the audit being planned and conducted in accordance with ISAs (UK) there remains an unavoidable risk that material misstatements in the financial statements may not be detected owing to inherent limitations of the audit, and that by their very nature, any such instances of fraud or irregularity likely involve collusion, forgery, intentional misrepresentations, or the override of internal controls.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
Use Of Our Report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters that we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Page 6
Page 7
Independent Auditor's Report (continued)
to the Members of
Absolute Healthcare North Limited

Mr Daniel Johnson FCCA (Senior Statutory Auditor) for and on behalf of Nuvo Audit Limited , Statutory Auditor
2 June 2026
Nuvo Audit Limited First Floor, Sterling House Outrams Wharf Little Eaton Derby DE21 5EL

Page 7
Page 8
Absolute Healthcare North Limited
Profit and Loss Account
For The Year Ended 30 April 2025
Profit and Loss Account

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| Notes | £ |  | £
Administrative expenses |  | (77,232 ) |  | (89,136 )
OPERATING LOSS | 3 | (77,232 ) |  | (89,136 )
Income from Shares in group undertakings |  | 3,500,000 |  | 2,200,000
PROFIT BEFORE TAXATION |  | 3,422,768 |  | 2,110,864
Tax on Profit | 7 | 10,725 |  | (82,183 )
PROFIT AFTER TAXATION BEING PROFIT FOR THE FINANCIAL YEAR |  | 3,433,493 |  | 2,028,681

The notes on pages 13 to 17 form part of these financial statements.
Page 8
Page 9
Absolute Healthcare North Limited
Statement of Comprehensive Income
For The Year Ended 30 April 2025
Statement of Comprehensive Income

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
PROFIT FOR THE FINANCIAL YEAR |  | 3,433,493 |  | 2,028,681
OTHER COMPREHENSIVE INCOME FOR THE YEAR |  | - |  | -
Prior year adjustment |  | (189,274) |  | -
TOTAL COMPREHENSIVE INCOME FOR THE YEAR |  | 3,244,219 |  | 2,028,681

Page 9
Page 10
Absolute Healthcare North Limited
Balance Sheet
As At 30 April 2025
Balance Sheet
Registered number: 10826548

| 2025 | 2024 as restated
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 8 |  | 5,935,392 |  | 5,996,477
Investments | 9 |  | 1 |  | 1
|  |  | 5,935,393 |  | 5,996,478
CURRENT ASSETS
Debtors | 10 | 1,761,522 |  | 169,200 |
Cash at bank and in hand |  | 2,231 |  | 4,878 |
|  | 1,763,753 |  | 174,078 |
Creditors: Amounts Falling Due Within One Year | 11 | (2,033,185 ) |  | (4,015,309 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (269,432 ) |  | (3,841,231 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 5,665,961 |  | 2,155,247
PROVISIONS FOR LIABILITIES
Deferred Taxation | 12 |  | (266,495 ) |  | (189,274 )
NET ASSETS |  |  | 5,399,466 |  | 1,965,973
CAPITAL AND RESERVES
Called up share capital | 14 |  | 6 |  | 6
Profit and Loss Account |  |  | 5,399,460 |  | 1,965,967
SHAREHOLDERS' FUNDS |  |  | 5,399,466 |  | 1,965,973

On behalf of the board

Mr D J Bunker Director
29 May 2026

The notes on pages 13 to 17 form part of these financial statements.
Page 10
Page 11
Absolute Healthcare North Limited
Statement of Changes in Equity
For The Year Ended 30 April 2025
Statement of Changes in Equity

| Share Capital | Profit and Loss Account | Total
--- | --- | --- | ---
| £ | £ | £
As at 1 May 2023 | 6 | (62,714 ) | (62,708)
Profit for the year and total comprehensive income | - | 2,028,681 | 2,028,681
As at 30 April 2024 | 6 | 1,965,967 | 1,965,973
As at 1 May 2024 as previously stated | 6 | 2,155,241 | 2,155,247
Prior year adjustment | - | (189,274 ) | (189,274 )
As at 1 May 2024 as restated | 6 | 1,965,967 | 1,965,973
1,965,967
Profit for the year and total comprehensive income | - | 3,433,493 | 3,433,493
As at 30 April 2025 | 6 | 5,399,460 | 5,399,466

Page 11
Page 12
Absolute Healthcare North Limited
Statement of Cash Flows
For The Year Ended 30 April 2025
Statement of Cash Flows

| 2025 |  | 2024 as restated
| Notes | £ |  | £
Cash flows from operating activities
Net cash used in operations | 1 | (97,755 ) |  | (2,248 )
Net cash used in operating activities |  | (97,755 ) |  | (2,248 )
Cash flows from investing activities
Amounts repaid to associated companies |  | (1,900,000) |  | (3,137,438)
Amounts received from group companies |  | 1,995,108 |  | 3,143,240
Net cash generated from investing activities |  | 95,108 |  | 5,802
(Decrease)/increase in cash and cash equivalents |  | (2,647 ) |  | 3,554
Cash and cash equivalents at beginning of year | 2 | 4,878 |  | 1,324
Cash and cash equivalents at end of year | 2 | 2,231 |  | 4,878

Page 12
Page 13
Absolute Healthcare North Limited
Notes to the Statement of Cash Flows
For The Year Ended 30 April 2025
Notes to the Statement of Cash Flows
1. Reconciliation of profit for the financial year to cash used in operations

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Profit for the financial year | 3,433,493 |  | 2,028,681
Adjustments for:
Tax on profit | (10,725 ) |  | 82,183
Income from shares in group undertakings | (3,500,000) |  | (2,200,000)
Depreciation of tangible assets | 61,085 |  | 61,085
Movements in working capital:
Decrease in trade and other debtors | 516 |  | 608
(Decrease)/increase in trade and other creditors | (82,124 ) |  | 25,195
Net cash used in operations | (97,755 ) |  | (2,248 )

2. Cash and cash equivalents
Cash and cash equivalents, as stated in the Statement of Cash Flows, relates to the following items in the Balance Sheet:

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Cash at bank and in hand | 2,231 |  | 4,878

3. Analysis of changes in net funds

| As at 1 May 2024 | Cash flows | As at 30 April 2025
--- | --- | --- | ---
| £ | £ | £
Cash at bank and in hand | 4,878 | (2,647) | 2,231

Page 13
Page 14
Absolute Healthcare North Limited
Notes to the Financial Statements
For The Year Ended 30 April 2025
Notes to the Financial Statements
1. General Information
Absolute Healthcare North Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10826548 . The registered office is The Scalpel, 18th Floor, 52 Lime Street, London, EC3M 7AF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Freehold | 1% Straight line basis

2.3. Investments
2.4. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
3. Operating Loss
The operating loss is stated after charging:

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Depreciation of tangible fixed assets | 61,085 |  | 61,085

Page 14
Page 15
Absolute Healthcare North Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 April 2025
4. Auditor's Remuneration
Remuneration received by the company's auditors and their associates during the year was as follows:

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Audit Services
Audit of the company's financial statements | 12,000 |  | 9,000

5. Average Number of Employees
Average number of employees, including directors, during the year was as follows:

| 2025 |  | 2024
--- | --- | --- | ---
| 1 |  | 1

6. Interest Receivable and Similar Income

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Dividends from shares in subsidiaries | 3,500,000 |  | 2,200,000

7. Tax on Profit
The tax (credit)/charge on the profit for the year was as follows:

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Current tax
UK Corporation Tax | (87,946 ) |  | (107,091 )
Deferred Tax
Deferred taxation | 77,221 |  | 189,274
Total tax charge for the period | (10,725 ) |  | 82,183

The actual (credit)/charge for the year can be reconciled to the expected charge for the year based on the profit and the standard rate of corporation tax as follows:

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Profit before tax | 3,422,768 |  | 2,110,864
Tax on profit at 0% (UK standard rate) | - |  | -
Capital allowances | 77,221 |  | 189,274
Group relief | (87,946 ) |  | (107,091 )
Total tax charge for the period | (10,725) |  | 82,183

Page 15
Page 16
Absolute Healthcare North Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 April 2025
8. Tangible Assets

| Land & Property
--- | ---
| Freehold
| £
Cost
As at 1 May 2024 | 6,108,466
As at 30 April 2025 | 6,108,466
Depreciation
As at 1 May 2024 | 111,989
Provided during the period | 61,085
As at 30 April 2025 | 173,074
Net Book Value
As at 30 April 2025 | 5,935,392
As at 1 May 2024 | 5,996,477

9. Investments

| Subsidiaries
--- | ---
| £
Cost or Valuation
As at 1 May 2024 | 1
As at 30 April 2025 | 1
Provision
As at 1 May 2024 | -
As at 30 April 2025 | -
Net Book Value
As at 30 April 2025 | 1
As at 1 May 2024 | 1

10. Debtors

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Due within one year
Amounts owed by group undertakings | 1,761,522 |  | 169,200

Page 16
Page 17
Absolute Healthcare North Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 April 2025
11. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Trade creditors | - |  | 95,300
Amounts owed to participating interests | 1,991,982 |  | 3,892,499
Accruals and deferred income | 41,203 |  | 27,510
| 2,033,185 |  | 4,015,309

12. Deferred Taxation
The provision for deferred tax is made up as follows:

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Other timing differences | 266,495 |  | 189,274

13. Provisions for Liabilities

| Deferred Tax | Total
--- | --- | ---
| £ | £
As at 1 May 2024 | 189,274 | 189,274
Additions | 77,221 | 77,221
Balance at 30 April 2025 | 266,495 | 266,495

14. Share Capital

| 2025 |  | 2024 as restated
--- | --- | --- | ---
Allotted, called up and fully paid | £ |  | £
6 Ordinary Shares of £ 1.000 each | 6 |  | 6

15. Financial Instruments
The company has the following financial instruments:

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Financial assets
Financial assets that are debt Instruments measured at amortised cost | 1,763,753 |  | 174,078

Financial liabilities
Financial liabilities measured at amortised cost | 2,033,185 |  | 4,015,309

Page 17